Latest Regulatory Approval News

Apollo Minerals reports encouraging exploration results from its Gabon projects, highlighting significant gold intercepts at Salanie and a substantial zinc-lead target at Kroussou, while navigating funding constraints and ongoing legal challenges in Europe.

Midas Minerals has secured unconditional approval from Namibia’s Competition Commission, paving the way to complete its acquisition of the Otavi Copper Project and launch an aggressive drilling campaign.

Cooper Metals is gearing up for drilling at its Mt Isa East copper-gold project while divesting a majority stake in its Gilberton Gold Project to Sybella Metals, maintaining a solid cash position to fund exploration.

Superior Resources has boosted its Greenvale Project area by 56%, revealing exceptional copper-gold-silver assay results and advancing its Steam Engine Gold Project towards production within two years.

Australian Vanadium Limited advances its vertically integrated vanadium strategy with key regulatory approvals, manufacturing expansions, and a new $10 million loan facility, positioning itself for major energy storage projects.

NewPeak Metals has completed acquisition of 100% ownership of the Las Opeñas exploration permits in Argentina, with drilling scheduled for early 2026. The company also advances drilling preparations at its Tansey Gold Project in Australia, supported by strong insider buying.

BCAL Diagnostics has secured key partnerships and a $10 million convertible note facility to expand its cancer detection tests across Australia and New Zealand, marking steady commercial progress in Q3 2025.

PainChek Ltd has achieved a pivotal FDA De Novo clearance for its AI-driven Adult pain assessment app, unlocking the US market and driving its annual recurring revenue to $5.6 million. The company also launched its Infant app, targeting a vast global market of pre-verbal children.

PainChek has secured FDA De Novo clearance for its Adult App, opening immediate access to a $175 million AUD US long-term care market and advancing its Infant App commercialization targeting a $15 billion AUD global opportunity.

Race Oncology has filed pivotal patents on the active (E,E)-bisantrene isomer, potentially extending its drug exclusivity by two decades, while advancing its Phase 1 clinical trial and maintaining a strong cash position.

Taiton Resources has completed key soil sampling programs targeting gold and rare earth elements at its South Australian projects, alongside heritage surveys and regulatory steps, supported by a recent $2 million capital raise.

Sarytogan Graphite Limited reports strong progress in graphite and copper exploration, securing key DFS contracts and a $3.6 million placement to advance its flagship projects.